Back to Search
Start Over
Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis.
- Source :
-
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2017 May; Vol. 23 (6), pp. 872-874. Date of Electronic Publication: 2017 Feb 01. - Publication Year :
- 2017
-
Abstract
- Nocardia is a Gram-positive aerobic pathogen that usually affects immunocompromised patients. We report a case of pulmonary infection caused by a rare Nocardia species, Nocardia beijingensis, in a 50-year-old woman who had received alemtuzumab for the treatment of her multiple sclerosis. The invasive pulmonary infection was successfully treated with meropenem.
- Subjects :
- Alemtuzumab
Anti-Bacterial Agents administration & dosage
Female
Humans
Immunocompromised Host
Meropenem
Middle Aged
Sepsis diagnosis
Sepsis drug therapy
Sepsis etiology
Thienamycins administration & dosage
Anti-Bacterial Agents pharmacology
Antibodies, Monoclonal, Humanized adverse effects
Immunologic Factors adverse effects
Multiple Sclerosis, Relapsing-Remitting drug therapy
Nocardia Infections diagnosis
Nocardia Infections drug therapy
Nocardia Infections etiology
Pneumonia, Bacterial diagnosis
Pneumonia, Bacterial drug therapy
Pneumonia, Bacterial etiology
Thienamycins pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1477-0970
- Volume :
- 23
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publication Type :
- Academic Journal
- Accession number :
- 28290754
- Full Text :
- https://doi.org/10.1177/1352458517694431